Hem › Burkitts lymfom › Georgia › Atlanta
Kliniska studier för Burkitts lymfom i Atlanta, GA
12 studier för Burkitts lymfom söker deltagare vid platser i och runt Atlanta (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
RekryterarFas 2
- Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
RekryterarFas 3
- Emory University Hospital/Winship Cancer Institute, Atlanta
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
RekryterarObservationsstudie
- Children's Healthcare of Atlanta - Arthur M. Blank Hospital, Atlanta
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
RekryterarFas 2
- Emory University Hospital/Winship Cancer Institute, Atlanta
- Emory Saint Joseph's Hospital, Atlanta
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
RekryterarFas 2
- Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)
RekryterarFas 1
- Winship Cancer Institute Emory University, Atlanta
- Northside Hospital Cancer Institute, Atlanta
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
RekryterarFas 2
- Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
RekryterarFas 3
- Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
RekryterarFas 1/2
- Research Site, Atlanta
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
RekryterarFas 2
- Children's Healthcare of Atlanta at Egleston, Atlanta
Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL
RekryterarFas 1
- Winship Cancer Institute, Emory University, Atlanta
The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL
RekryterarFas 2
- Children's Healthcare of Atlanta, Atlanta
Burkitts lymfom-studier i andra städer
- Houston, TX21 studier
- Philadelphia, PA16 studier
- Milwaukee, WI16 studier
- Chicago, IL15 studier
- New York City, NY13 studier
- Cincinnati, OH13 studier
- Aurora, CO11 studier
- Seattle, WA11 studier
- Durham, NC10 studier
- Kansas City, MO10 studier
- Boston, MA10 studier
- Los Angeles, CA10 studier
Andra studier i Atlanta
- Cancer (alla typer)49 studier
- Icke-småcellig lungcancer47 studier
- Multipelt myelom42 studier
- Bröstcancer41 studier
- Prostatacancer33 studier
- Akut myeloid leukemi31 studier
- Äggstockscancer29 studier
- Kolorektal cancer29 studier
- Lungcancer29 studier
- Metastaserande cancer28 studier
- Major depression25 studier
- Hjärtsvikt25 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.